Exagen Inc.
XGN
$8.63
$0.232.74%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 1.93% | 19.91% | 36.19% | 47.87% | 50.74% |
Total Depreciation and Amortization | -12.81% | -17.70% | -20.48% | -16.74% | -0.84% |
Total Amortization of Deferred Charges | 27.92% | 5.30% | -1.28% | -7.45% | -5.52% |
Total Other Non-Cash Items | -26.68% | -52.16% | -53.88% | -54.76% | -49.48% |
Change in Net Operating Assets | -224.30% | -56.65% | -1,046.46% | 153.77% | 134.22% |
Cash from Operations | -155.09% | -8.41% | 8.18% | 81.46% | 81.36% |
Capital Expenditure | -86.36% | -4.63% | 37.80% | 57.89% | 83.54% |
Sale of Property, Plant, and Equipment | -72.73% | -75.00% | -- | 1,000.00% | 1,000.00% |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -97.73% | -8.50% | 35.95% | 59.77% | 84.62% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -2,220.90% | 91.57% | 92.13% | 92.09% | 91.86% |
Issuance of Common Stock | 8,155.41% | 26.41% | -35.29% | -46.05% | -41.37% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 3,392.35% | 94.12% | 93.76% | 93.70% | 93.77% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 179.49% | 35.49% | 44.18% | 84.07% | 84.41% |